Literature DB >> 20383664

Effect of daptomycin on primary rat muscle cell cultures in vitro.

Tatiana Y Kostrominova1, Scott Coleman, Frederick B Oleson, John A Faulkner, Lisa M Larkin.   

Abstract

Daptomycin is a lipopeptide antibiotic that has strong bactericidal activity against Gram-positive bacteria and that was previously reported to exhibit minor side effects on skeletal muscle. This study was designed to further characterize the effect of daptomycin on skeletal muscle through the use of primary cultures of muscles from rats. Our investigations demonstrated that daptomycin has a concentration-dependent and time-dependent effect on the plasma membrane of primary cultures of differentiated, spontaneously contracting rat myotubes. No effects were evident in non-differentiated myoblasts or other mononucleated cells present in cultures even at the highest daptomycin concentrations tested (6,000 microg/mL). In cultures treated with daptomycin at a concentration of 2,000 microg/mL, plasma membrane damage was observed in approximately 20-30% of differentiated myotubes; no myotube damage was detected at concentrations of 1,000 microg/mL and below. A transient loss of spontaneous myotube contractions was evident at 750 microg/mL, while at 2,000 microg/mL and above, a permanent loss of spontaneous contractility was observed. These results suggest that the putative targets for daptomycin effects on skeletal muscle are structures on the plasma membrane of highly differentiated myotubes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383664     DOI: 10.1007/s11626-010-9311-5

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  15 in total

1.  Mechanisms of doxycycline-induced cytotoxicity on human bronchial epithelial cells.

Authors:  Matthieu Sourdeval; Christophe Lemaire; Catherine Brenner; Emmanuelle Boisvieux-Ulrich; Francelyne Marano
Journal:  Front Biosci       Date:  2006-09-01

2.  Structure and functional evaluation of tendon-skeletal muscle constructs engineered in vitro.

Authors:  Lisa M Larkin; Sarah Calve; Tatiana Y Kostrominova; Ellen M Arruda
Journal:  Tissue Eng       Date:  2006-11

3.  Properties and role of voltage-dependent calcium channels during mouse skeletal muscle differentiation.

Authors:  Isabelle Bidaud; Arnaud Monteil; Joël Nargeot; Philippe Lory
Journal:  J Muscle Res Cell Motil       Date:  2006-03-15       Impact factor: 2.698

4.  Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells.

Authors:  M Mannerström; M Zorn-Kruppa; H Diehl; M Engelke; T Toimela; H Mäenpää; A Huhtala; H Uusitalo; L Salminen; P Pappas; M Marselos; M Mäntylä; E Mäntylä; H Tähti
Journal:  Toxicol In Vitro       Date:  2002-04       Impact factor: 3.500

Review 5.  The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.

Authors:  M J Rybak
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

Review 6.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors:  Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

7.  Once-daily dosing in dogs optimizes daptomycin safety.

Authors:  F B Oleson; C L Berman; J B Kirkpatrick; K S Regan; J J Lai; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  An in vitro model for assessing muscle irritation due to parenteral antibiotics.

Authors:  P D Williams; B G Masters; L D Evans; D A Laska; G H Hottendorf
Journal:  Fundam Appl Toxicol       Date:  1987-07

9.  In vitro correlation of ultrastructural morphology and creatine phosphokinase release in L6 skeletal muscle cells after exposure to parenteral antibiotics.

Authors:  D A Laska; P D Williams; S L White; C A Thompson; D M Hoover
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

10.  Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.

Authors:  Jared A Silverman; Nancy G Perlmutter; Howard M Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more
  6 in total

1.  Safety analysis of high dose (>6 mg/kg/day) daptomycin in patients with concomitant statin therapy.

Authors:  J Parra-Ruiz; C Dueñas-Gutiérrez; C Tomás-Jiménez; J P Linares-Palomino; J Garrido-Gomez; J Hernández-Quero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-08       Impact factor: 3.267

2.  NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.

Authors:  Wooseong Kim; Nico Fricke; Annie L Conery; Beth Burgwyn Fuchs; Rajmohan Rajamuthiah; Elamparithi Jayamani; Petia M Vlahovska; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-02-24       Impact factor: 3.808

3.  Daptomycin, a last-resort antibiotic, binds ribosomal protein S19 in humans.

Authors:  Michael P Gotsbacher; Sungmin Cho; Ho Jeong Kwon; Peter Karuso
Journal:  Proteome Sci       Date:  2017-07-01       Impact factor: 2.480

4.  Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection.

Authors:  Alberto V Carli; Andy O Miller; Milan Kapadia; Yu-Fen Chiu; Geoffrey H Westrich; Barry D Brause; Michael W Henry
Journal:  J Bone Jt Infect       Date:  2020-03-30

5.  A Retrospective Multisite Case-Control Series of Concomitant Use of Daptomycin and Statins and the Effect on Creatine Phosphokinase.

Authors:  Bethany Lehman; Elizabeth A Neuner; Victor Heh; Carlos Isada
Journal:  Open Forum Infect Dis       Date:  2019-11-07       Impact factor: 3.835

Review 6.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.